Amylin Development Candidate Selection: ACCG-2671 (December 2024) 1.5 MB GSBR-1290 Phase 2 ACCESS Program (November 2024) 761.5 KB Structure Therapeutics GSBR-1290 Obesity Data (June 2024) 1 MB